0.00Open0.00Pre Close0 Volume0 Open Interest31.00Strike Price0.00Turnover225.88%IV-59.47%PremiumOct 11, 2024Expiry Date11.56Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9696Delta0.0159Gamma1.68Leverage Ratio-0.0287Theta-0.0021Rho-1.62Eff Leverage0.0014Vega
Hims & Hers Health Stock Discussion
Just past 4 pm ET the $S&P 500 Index (.SPX.US)$ traded down 0.96%, the $Dow Jones Industrial Average (.DJI.US)$ fell 0.94%, and the $Nasdaq Composite Index (.IXIC.US)$ fell 1.18%.
MACRO
Last week was a volatile one, but this week, we wil...
My name is Kevin Travers; here are stonks and stories you have to know about on Wall Street today.
$Hims & Hers Health (HIMS.US)$ shares are trading 9...
Gapping up
$Pfizer (PFE.US)$ stock increased by 3.4% following a Bloomberg report that activist investor Starboard Value acquired approximately $1 billion in shares of the pharmaceutical giant, aiming to drive a turnaround for the company.
$Hims & Hers Health (HIMS.US)$ saw its stock rise by 5.4% after it was announced that the telehealth company would be joining the S&P SmallCap 600, replacing Vector Group, the...
nailed it
Their obesity drug is not affected by the side effects discovered by Novo Nordisk.
Novo's drug is CB1 receptor based
HIMS' is manufactured by Nivagen and is a GLP-1 injection.
No comment yet